Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes

被引:0
|
作者
Khan, Ahsan Ali [1 ]
Khalid, Muhammad Usman [1 ]
Bajwa, Mohammad Hamza [1 ]
Urooj, Faiza [1 ]
Tahir, Izza [2 ]
Angez, Meher [2 ]
Zahid, Fahad [1 ]
Baqai, Muhammad Waqas Saeed [1 ]
Aftab, Kiran [1 ]
Ansari, Shahabuddin [3 ]
Khan, Ummul Wara [1 ]
Ahmed, Ali Azan [2 ]
Enam, Syed Ather [1 ]
机构
[1] Aga Khan Univ, Dept Surg, Karachi, Pakistan
[2] Aga Khan Univ, Med Coll, Karachi, Pakistan
[3] GIK Inst Engn Sci & Technol, Dept Comp Sci, Topi, Pakistan
关键词
Circumscribed; Infiltrating; Lower-grade; Glioma; Clinical outcomes; Radiological features; CENTRAL-NERVOUS-SYSTEM; TUMORS; MUTATIONS;
D O I
10.1016/j.wnsx.2024.100356
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We hypothesize that lower grade gliomas (LGG) can be identified and classified into two distinct subtypes: radiologically circumscribed Lower-Grade Gliomas (cLGG) and infiltrating Lower-Grade Gliomas (iLGG) based on radiological parameters and that these two different subtypes behave differently in terms of clinical outcomes. Methods: We conducted a retrospective cohort study on surgical patients diagnosed with lower grade glioma over five years. Patient records and MRIs were reviewed, and neurosurgeons classified tumors into cLGG and iLGG groups. Results: From the 165 patients in our cohort, 30 (18.2%) patients were classified as cLGG and 135 (81.8%) patients were classified as iLGG Mean age in cLGG was 31.4 years while mean age in iLGG was 37.9 years (p = 0.004). There was significant difference in mean blood loss between cLGG and iLGG groups (270 and 411 ml respectively, p = 0.020). cLGG had a significantly higher proportion of grade II tumors (p < 0.001). The overall mean survival time for the iLGG group was 14.96 +/- 1.23 months, and 18.77 +/- 2.72 months for the cLGG group. In univariate cox regression, the survival difference between LGG groups was not significant (HR = 0.888, p = 0.581), however on multivariate regression cLGG showed a significant (aHZ = 0.443, p = 0.015) positive correlation with survival. Intense contrast enhancement (HZ = 41.468, p = 0.018), blood loss (HZ = 1.002, p = 0.049), and moderately high Ki-67 (HZ = 4.589, p = 0.032) were also significant on univariate analyses. Conclusion: cLGG and iLGG are radiologically distinct groups with separate prognoses, surgical experience, and associations.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] GENOMIC ANALYSIS, SURGICAL TREATMENT AND OUTCOMES OF LOWER-GRADE GLIOMAS IN A SINGLE INSTITUTION
    Eagle, David
    Merla, Anca
    McKevitt, Fiona
    Clenton, Susan
    Bridgewater, Caroline
    Wharton, Stephen
    Zaki, Hesham
    Jellinek, David
    Ushewokunze, Shungu
    NEURO-ONCOLOGY, 2017, 19 : 238 - 238
  • [22] Response to: "Prognostic relevance of epilepsy at presentation in lower-grade gliomas"
    Berendsen, Sharon
    Snijders, Tom J.
    Robe, Pierre A.
    NEURO-ONCOLOGY, 2016, 18 (09) : 1327 - 1328
  • [23] ASSOCIATION BETWEEN GLIOBLASTOMA MOLECULAR SUBTYPES AND LOWER-GRADE GLIOMAS
    Guan, Xiaowei
    Vengoechea, Jaime
    Zheng, Siyuan
    Sloan, Andrew
    Chen, Yanwen
    Brat, Daniel
    O'Neill, Brian P.
    Cohen, Mark
    Aldape, Kenneth
    Rosenfeld, Steven
    Noushmehr, Houtan
    Verhaak, Roeland G.
    Barnholtz-Sloan, Jill
    NEURO-ONCOLOGY, 2012, 14 : 92 - 92
  • [24] A prognostic signature of five pseudogenes for predicting lower-grade gliomas
    Liu, Bo
    Liu, Jingping
    Liu, Kun
    Huang, Hao
    Li, Yexin
    Hu, Xiqi
    Wang, Ke
    Cao, Hui
    Cheng, Quan
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [25] GENOMIC ANALYSIS, SURGICAL TREATMENT AND OUTCOMES OF LOWER-GRADE GLIOMAS IN A SINGLE INSTITUTION
    Eagle, David
    Merla, Anca
    Ushewokunze, Shungu O.
    Jellinek, David
    Zaki, Hesham
    Wharton, Stephen
    Mckevitt, Fiona
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [26] Multicellular "hotspots" harbor high-grade potential in lower-grade gliomas
    Kirby, Alastair J.
    Lavrador, Jose P.
    Bodi, Istvan
    Vergani, Francesco
    Bhangoo, Ranjeev
    Ashkan, Keyoumars
    Finnerty, Gerald T.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [27] ZEB1 expression in Chinese lower-grade gliomas
    Xiangyan Huang
    Harrison X. Bai
    Li Yang
    Journal of Neuro-Oncology, 2017, 133 : 213 - 215
  • [28] RADIOMICS ANALYSIS OF LOWER-GRADE GLIOMAS, A POLA NETWORK STUDY
    Younan, N.
    Douzane, H.
    Duran-Pena, A.
    Nichelli, L.
    Garcilazo, Y.
    Dehais, C.
    Ducray, F.
    Carpentier, C.
    Mokhtari, K.
    Figarella-Branger, D.
    Delattre, J.
    Idbaih, A.
    Alentorn, A.
    NEURO-ONCOLOGY, 2019, 21 : 18 - 18
  • [29] Spermine Synthase : A Potential Prognostic Marker for Lower-Grade Gliomas
    Liu, Chen
    Li, Hongqi
    Hu, Xiaolong
    Yan, Maohui
    Fu, Zhiguang
    Zhan, Henheng
    Wang, Yingjie
    Du, Nan
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2025, 68 (01) : 75 - 96
  • [30] Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
    Aoki, Kosuke
    Nakamura, Hideo
    Suzuki, Hiromichi
    Matsuo, Keitaro
    Kataoka, Keisuke
    Shimamura, Teppei
    Motomura, Kazuya
    Ohka, Fumiharu
    Shiina, Satoshi
    Yamamoto, Takashi
    Nagata, Yasunobu
    Yoshizato, Tetsuichi
    Mizoguchi, Masahiro
    Abe, Tatsuya
    Momii, Yasutomo
    Muragaki, Yoshihiro
    Watanabe, Reiko
    Ito, Ichiro
    Sanada, Masashi
    Yajima, Hironori
    Morita, Naoya
    Takeuchi, Ichiro
    Miyano, Satoru
    Wakabayashi, Toshihiko
    Ogawa, Seishi
    Natsume, Atsushi
    NEURO-ONCOLOGY, 2018, 20 (01) : 66 - 77